Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BMI1 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
mRNA | NKX2-2 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
mRNA | MYO9A | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
mRNA | DLX1 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
mRNA | PLPP3 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
mRNA | TPRN | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
mRNA | FDXACB1 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
mRNA | MPC1L | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
mRNA | FUT10 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
mRNA | ZNF644 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |